Two Sigma Investments
DWTX

Two Sigma Investments’s Dogwood Therapeutics DWTX Stock Holding History

Two Sigma Investments’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-711
Closed -$94K – 4992
2021
Q3 		$94K Sell
711
-454
-39% -$62.8K ﹤0.01% 4090
2021
Q2 		$183K Sell
1,165
-3,128
-73% -$443K ﹤0.01% 3807
2021
Q1 		$615K Buy
+4,293
New +$747K ﹤0.01% 2731

Other funds holding DWTX

MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Two Sigma Investments's DWTX Position: Q4 2021 in Review

Two Sigma Investments sold out of Dogwood Therapeutics (DWTX) in Q4 2021, closing a stake of 711 shares — an estimated $94K sold.

Two Sigma Investments first reported a position in DWTX in Q1 2021 and held it in 3 quarters. The position peaked at $615K in Q1 2021. 15 funds tracked by Wall St. Rank hold DWTX as of Q4 2021.

  • Two Sigma Investments reported no remaining Dogwood Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Two Sigma Investments sold 711 Dogwood Therapeutics shares in Q4 2021, an estimated $94K.
  • Two Sigma Investments first reported a position in Dogwood Therapeutics in Q1 2021 and held it in 3 quarters.
  • Two Sigma Investments's Dogwood Therapeutics position peaked at $615K in Q1 2021.
  • 15 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q4 2021.

Based on Two Sigma Investments's 13F filing for Q4 2021, filed 14 Feb 2022.